Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis:

Howard Thom,William Hollingworth,Reecha Sofat,Zhenru Wang,Wei Fang,Pritesh N. Bodalia,Peter Bryden,Philippa Davies,Deborah M Caldwell,Sofia Dias,Diane Eaton,Julian P. T. Higgins,Aroon D. Hingorani,José A. López-López,George Okoli,Alison Richards,Chris Salisbury,Jelena Savovic,Annya Stephens-Boal,Jonathan A C Sterne,Nicky J Welton

Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis:

2019

Objectives. Determine the optimal, licensed, first-line anticoagulant for prevention of ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales from the UK Natio...

Keywords:

Stroke
Medicine
Emergency medicine
Anticoagulant
Atrial fibrillation
Value of information
Cost-effectiveness analysis
ischemic stroke
in patient
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations